# From Synthesis to Therapeutics: Bioactive‐Coated Zein Nanoparticles in Drug Delivery

**Authors:** Milena Ferreira de Lima, Andy Joel Taipe Huisa, Azael da Silva Neto, Clarice Beatriz Gonçalves Silva, Iago Dillion Lima Cavalcanti, Karolliny Barbosa de Araújo, Mariane Cajubá de Britto Lira‐Nogueira, Nereide Stela Santos Magalhães, Priscila Gubert

PMC · DOI: 10.1002/bip.70088 · Biopolymers · 2026-03-15

## TL;DR

This review explores how zein nanoparticles coated with bioactive materials can improve drug delivery by enhancing stability and therapeutic effects.

## Contribution

The paper systematically reviews synthesis methods, coating materials, and biological activities of bioactive-coated zein nanoparticles.

## Key findings

- The antisolvent method is most commonly used for zein nanoparticle synthesis due to its simplicity and cost-effectiveness.
- Chitosan is identified as the preferred coating material for improving nanoparticle stability and performance.
- Bioactive-coated zein nanoparticles show antioxidant, anticancer, and other therapeutic properties in preclinical studies.

## Abstract

Polymeric zein nanoparticles (ZNP), derived from corn protein, are biodegradable drug carriers with high stability and low synthesis costs. Their amphiphilic nature allows efficient encapsulation of both hydrophilic and lipophilic drugs, making them promising for drug delivery. However, their instability under physiological pH can limit therapeutic efficacy, necessitating protective coatings for improved absorption. This review discusses synthesis methods, coating materials, and biological activities of bioactive‐coated ZNP. We found that the antisolvent method is the most commonly used due to its simplicity and cost‐effectiveness, while chitosan is the preferred coating material. ZNP exhibit antioxidant, anticancer, anesthetic, antidiabetic, hypoglycemic, and immunogenic properties, as demonstrated in both in vitro and in vivo studies. Their ability to enhance bioavailability, reduce toxicity, and enable targeted drug delivery highlights their potential in nanomedicine.

## Linked entities

- **Chemicals:** chitosan (PubChem CID 129662530)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Fabp6 (fatty acid binding protein 6) [NCBI Gene 16204] {aka GT, I-15P, I-BABP, ILBP, ILBP3, Illbp}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Cdk9 (cyclin dependent kinase 9) [NCBI Gene 107951] {aka PITALRE}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Htr4 (5 hydroxytryptamine (serotonin) receptor 4) [NCBI Gene 15562] {aka 5-HT-4, 5-HT4, 5-HT<4L>, 5HTR4}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Il22 (interleukin 22) [NCBI Gene 50929] {aka IL-22, IL-22a, ILTIFa, If2b1, Iltif}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Igha (immunoglobulin heavy constant alpha) [NCBI Gene 238447] {aka IgA, Igh-2}, Cdk7 (cyclin dependent kinase 7) [NCBI Gene 12572] {aka C230069N13, CAK, Cdkn7, Crk4, P39 Mo15}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Ltf (lactotransferrin) [NCBI Gene 17002] {aka Csp82, Lf, MMS10R, Ms10r}, Ighv1-9 (immunoglobulin heavy variable 1-9) [NCBI Gene 668478] {aka Gm16697, Igg2a}, mucin [NCBI Gene 100508689], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** lymph node metastasis (MESH:D008207), Cytotoxicity (MESH:D064420), breast adenocarcinoma (MESH:D001943), cardiovascular diseases (MESH:D002318), synovial damage (MESH:D013581), colon adenocarcinoma (MESH:D003110), Neurotoxicity (MESH:D020258), hepatocellular carcinoma (MESH:D006528), diabetes (MESH:D003920), ovarian carcinoma (MESH:D010051), abnormal (MESH:D000014), steatosis (MESH:D005234), prostate carcinoma (MESH:D011472), inflammatory (MESH:D007249), chronic myelogenous leukemia (MESH:D015464), cartilage and (MESH:D002357), cervical adenocarcinoma (MESH:D000230), hemolytic (MESH:D006461), renal tubular (MESH:D000141), infections (MESH:D007239), insulin resistance (MESH:D007333), epileptic (MESH:D004827), Ehrlich ascites carcinoma (MESH:D002286), bone metastasis (MESH:D009362), lung carcinoma (MESH:D008175), kidney damage (MESH:D007674), weight loss (MESH:D015431), Cancer (MESH:D009369), depressive (MESH:D003866), obesity (MESH:D009765), T2D (MESH:D003924)
- **Chemicals:** esculetin (MESH:C007628), CBZ (MESH:D002220), TC (MESH:D013667), MDA (MESH:D015104), Resveratrol (MESH:D000077185), Chitosan (MESH:D048271), Trolox (MESH:C010643), Thymol (MESH:D013943), I-NP (MESH:C090882), LPS (MESH:D008070), metal (MESH:D008670), 2,2-diphenyl-1-picryl-hydrazyl (MESH:C004931), NO (MESH:D009614), carbon nanotubes (MESH:D037742), CS (MESH:D002586), Dextran sulfate (MESH:D016264), polyphenol (MESH:D059808), mannosamine (MESH:C008322), Tanshinone (MESH:C021751), vitamin C (MESH:D001205), water (MESH:D014867), triglycerides (MESH:D014280), Dextran (MESH:D003911), Pectin (MESH:D010368), insulin (MESH:D007328), lipid (MESH:D008055), glucose (MESH:D005947), ABTS (MESH:C002502), DOX (MESH:D004317), Quercetin (MESH:D011794), Cel (MESH:C054688), polysaccharide (MESH:D011134), ATV (MESH:C076632), biopolymers (MESH:D001704), Z (MESH:C000597310), TG (MESH:D013866), Curcumin (MESH:D003474), CA (MESH:D002118), Colchicine (MESH:D003078), hydrogen (MESH:D006859), thiamine (MESH:D013831), ZpD (MESH:D000077334), FA (MESH:D005492), ROS (MESH:D017382), cholesterol (MESH:D002784), Orlistat (MESH:D000077403), CAZ-ZNP-CH (-), hypericin (MESH:C004965), PDA (MESH:C568283), creatinine (MESH:D003404), polymers (MESH:D011108), chitin (MESH:D002686), Ethanol (MESH:D000431), acid (MESH:D000143), Q (MESH:D005973), RES (MESH:D012211), Lutein (MESH:D014975), glycogen (MESH:D006003), GSH (MESH:D005978), blood glucose (MESH:D001786)
- **Species:** Homo sapiens (human, species) [taxon 9606], C. elegans [taxon 328850], Sorghum bicolor (broomcorn, species) [taxon 4558], Candida albicans (species) [taxon 5476], Oreochromis niloticus (Nile tilapia, species) [taxon 8128], Tremella fuciformis (snow fungus, species) [taxon 64657], Caenorhabditis elegans (species) [taxon 6239], Mus musculus (house mouse, species) [taxon 10090], Danio rerio (leopard danio, species) [taxon 7955], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** CAT by 56, F18 E
- **Cell lines:** L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), LNCaP — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0395), PC-3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), HSF — Homo sapiens (Human), Finite cell line (CVCL_A9FC), C6 glioma — Rattus norvegicus (Rat), Rat malignant glioma, Cancer cell line (CVCL_3581), SKOV-3 — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0532), WI-38 — Homo sapiens (Human), Finite cell line (CVCL_0579), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), NCM 460 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0460), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), NIH-3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), AML12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0140), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), DU145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989642/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12989642/full.md

## References

128 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989642/full.md

---
Source: https://tomesphere.com/paper/PMC12989642